Ropivacaine and Bupivacaine in Sphenopalatine Ganglion Block in Sinus Surgery

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Postoperative analgesia after FESS can be achieved through opioids, NSAIDs, topical or infiltration of local anaesthetic and regional techniques like sphenopalatine ganglion (SPG) block, infraorbital nerve block and nasociliary block. As the current evidences regarding the benefit of SPG block after FESS is controversial, efficacy of sphenopalatine ganglion block will be evaluated using bupivacaine or ropivacaine as local anaesthetic in adult patients undergoing FESS under general anaesthesia in this study.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Postgraduate Institute of Medical Education and Research
• Treatments: Bupivacaine; Ropivacaine

Criteria

Inclusion Criteria:

• 60 American Society of Anesthesiologists (ASA) physical status I and II patients

• aged 18-60 years scheduled to undergo elective functional endoscopic sinus surgery for sinonasal disease such as rhinosinusitis, polyps and deviated nasal septum were enrolled

Exclusion Criteria:

• Severe cardiovascular, pulmonary, hepatic, renal, neurologic or metabolic disease or coagulopathy

• History of allergy to any of the medications being used in the study

• Previous surgery for sinonasal disease

• Pre-existing chronic pain not related to chronic rhinosinusitis

• Taking prescription pain medications or antidepressants

• Chronic alcohol or drug abuse

• Inability to comprehend the study protocol

• Pregnancy